Bio News

• Bio News

  Important Pharma/Biotech Meetings & Conferences in 2024

  2024年9月20日 5.5K0
• Bio News

  【Weekly Headline News】August 26~September 1, 2024 (Updated in real time~~ Chinese version also updated~~)

  2024年8月31日 2.0K0
• Bio News

  Breaking News! Legend Biotech’s CAR-T product “Ciltacabtagene Autoleucel” has been approved in China

  2024年8月27日 9910
• Bio News

  Warm congratulations to Professors Deng Hongkui, Zhang Tao, Li Yadong, and Sun Binyong for winning the 2024 Future Science Prize!

  2024年8月26日 1140
• Bio News

  Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease

  2024年7月8日 1910
• Bio News

  The “Comprehensive Chain Support Plan for the Development of Innovative Medicines” has been reviewed and approved, and the industry has responded enthusiastically!

  2024年7月6日 5180
• Bio News

  Lilly’s Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer’s Disease

  2024年7月3日 2780
• Bio News

  Radionetics Oncology Enters Into Strategic Agreement With Lilly on its proprietary GPCR targeting small molecule radiopharmaceuticals

  2024年7月2日 1860
• Bio News

  Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

  2024年7月2日 1920
• Bio News

  Alnylam Reports Positive Topline Results from HELIOS-B Phase 3 Study of Vutrisiran, Achieving Statistical Significance on Primary and All Secondary Endpoints in Both Overall and Monotherapy Populations

  2024年6月24日 1900